The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease

Autor: Mario Masarone, Alessandro Federico, Filomena Morisco, Mario Romeo, Antonietta Gerarda Gravina, Concetta Tuccillo, Carmelina Loguercio, Sonia Errico, Marcello Persico, Nadia Diano, Paola Stiuso, Marcello Dallio
Přispěvatelé: Federico, A., Dallio, M., Gravina, A. G., Diano, N., Errico, S., Masarone, M., Romeo, M., Tuccillo, C., Stiuso, P., Morisco, F., Persico, M., Loguercio, C.
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Adult
Male
medicine.medical_specialty
endocrine system
Antioxidant
Health
Toxicology and Mutagenesis

medicine.medical_treatment
Cancer biology
lcsh:Medicine
medicine.disease_cause
Article
03 medical and health sciences
0302 clinical medicine
Insulin resistance
Phenols
Internal medicine
Vitamin D and neurology
TBARS
Humans
Medicine
Obesity
Benzhydryl Compounds
Benzhydryl Compound
urogenital system
business.industry
Vitamin E
lcsh:R
Fatty liver
Public Health
Environmental and Occupational Health

Oxidative Stre
Middle Aged
medicine.disease
Oxidative Stress
Endocrinology
Italy
Liver
030220 oncology & carcinogenesis
Homeostatic model assessment
030211 gastroenterology & hepatology
business
Oxidative stress
hormones
hormone substitutes
and hormone antagonists

Human
Non-alcoholic fatty liver disease
Zdroj: International Journal of Environmental Research and Public Health
Volume 17
Issue 10
International Journal of Environmental Research and Public Health, Vol 17, Iss 3369, p 3369 (2020)
Popis: Introduction: Bisphenol A (BPA) exposure has been correlated to non-alcoholic fatty liver disease (NAFLD) development and progression. We investigated, in a clinical model, the effects of the administration of 303 mg of silybin phospholipids complex, 10 g of vitamin D, and 15 mg of vitamin E (RealSIL, 100D, IBI-Lorenzini, Aprilia, Italy) in male NAFLD patients exposed to BPA on metabolic, hormonal, and oxidative stress-related parameters. Methods: We enrolled 32 male patients with histologic diagnosis of NAFLD and treated them with Realsil 100D twice a day for six months. We performed at baseline clinical, biochemical, and food consumption assessments as well as the evaluation of physical exercise, thiobarbituric acid reactive substances (TBARS), plasmatic and urinary BPA and estrogen levels. The results obtained were compared with those of healthy control subjects and, in the NAFLD group, between baseline and the end of treatment. Results: A direct proportionality between TBARS levels and BPA exposure was shown (p <
0.0001). The therapy determined a reduction of TBARS levels (p = 0.011), an improvement of alanine aminotransferase, aspartate aminotransferase, insulinemia, homeostatic model assessment insulin resistance, C reactive protein, tumor necrosis factor alpha (p <
0.05), an increase of conjugated BPA urine amount, and a reduction of its free form (p <
0.0001
p = 0.0002). Moreover, the therapy caused an increase of plasmatic levels of the native form of estrogens (p = 0.03). Conclusions: We highlighted the potential role of BPA in estrogen oxidation and oxidative stress in NAFLD patients. The use of Realsil 100D could contribute to fast BPA detoxification and to improve cellular antioxidant power, defending the integrity of biological estrogen-dependent pathways.
Databáze: OpenAIRE